Cargando…

Premature consent and patient duties

This paper addresses the problem of ‘premature consent’. The term ‘premature consent’ (introduced in a 2018 paper by J.K. Davis) denotes patient decisions that are: (i) formulated prior to discussion with the appropriate healthcare professional (HCP); (ii) based on information from unreliable source...

Descripción completa

Detalles Bibliográficos
Autores principales: Rebera, Andrew P., Dimitriou, Dimitris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557143/
https://www.ncbi.nlm.nih.gov/pubmed/33978880
http://dx.doi.org/10.1007/s11019-021-10024-5
_version_ 1784592313562955776
author Rebera, Andrew P.
Dimitriou, Dimitris
author_facet Rebera, Andrew P.
Dimitriou, Dimitris
author_sort Rebera, Andrew P.
collection PubMed
description This paper addresses the problem of ‘premature consent’. The term ‘premature consent’ (introduced in a 2018 paper by J.K. Davis) denotes patient decisions that are: (i) formulated prior to discussion with the appropriate healthcare professional (HCP); (ii) based on information from unreliable sources (e.g. parts of the internet); and (iii) resolutely maintained despite the HCP having provided alternative reliable information. HCPs are not obliged to respect premature consent patients’ demands for unindicated treatments. But why? What is it that premature consent patients do or get wrong? Davis has argued that premature consent patients are incompetent and misinformed. We argue that this view is not sustainable. A more plausible position asserts that premature consent threatens the integrity of the medical profession. We argue that this gives rise to a negative patient duty (to not obstruct HCPs in upholding the integrity of the medical profession) which premature consent patients fail to honour. We argue for a further positive duty of good faith engagement in shared decision-making. This implies willingness to potentially revise or justify one’s evaluative bases (core assumptions, beliefs, values, etc.). Fundamentally, the problem with premature consent patients is that certain of their evaluative bases are not open to revision. They therefore fail in their duty to participate faithfully in the shared decision-making process.
format Online
Article
Text
id pubmed-8557143
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-85571432021-11-15 Premature consent and patient duties Rebera, Andrew P. Dimitriou, Dimitris Med Health Care Philos Scientific Contribution This paper addresses the problem of ‘premature consent’. The term ‘premature consent’ (introduced in a 2018 paper by J.K. Davis) denotes patient decisions that are: (i) formulated prior to discussion with the appropriate healthcare professional (HCP); (ii) based on information from unreliable sources (e.g. parts of the internet); and (iii) resolutely maintained despite the HCP having provided alternative reliable information. HCPs are not obliged to respect premature consent patients’ demands for unindicated treatments. But why? What is it that premature consent patients do or get wrong? Davis has argued that premature consent patients are incompetent and misinformed. We argue that this view is not sustainable. A more plausible position asserts that premature consent threatens the integrity of the medical profession. We argue that this gives rise to a negative patient duty (to not obstruct HCPs in upholding the integrity of the medical profession) which premature consent patients fail to honour. We argue for a further positive duty of good faith engagement in shared decision-making. This implies willingness to potentially revise or justify one’s evaluative bases (core assumptions, beliefs, values, etc.). Fundamentally, the problem with premature consent patients is that certain of their evaluative bases are not open to revision. They therefore fail in their duty to participate faithfully in the shared decision-making process. Springer Netherlands 2021-05-12 2021 /pmc/articles/PMC8557143/ /pubmed/33978880 http://dx.doi.org/10.1007/s11019-021-10024-5 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Scientific Contribution
Rebera, Andrew P.
Dimitriou, Dimitris
Premature consent and patient duties
title Premature consent and patient duties
title_full Premature consent and patient duties
title_fullStr Premature consent and patient duties
title_full_unstemmed Premature consent and patient duties
title_short Premature consent and patient duties
title_sort premature consent and patient duties
topic Scientific Contribution
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557143/
https://www.ncbi.nlm.nih.gov/pubmed/33978880
http://dx.doi.org/10.1007/s11019-021-10024-5
work_keys_str_mv AT reberaandrewp prematureconsentandpatientduties
AT dimitrioudimitris prematureconsentandpatientduties